Improving lung cancer screening in the Bronx

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This initiative aims to enhance lung cancer screening rates in the Bronx, New York, by establishing a Centralized Screening Unit (CSU). The CSU will streamline the workflow for lung cancer screening, addressing barriers such as incomplete smoking histories and lack of patient navigation. By shifting responsibilities away from busy clinical practices, the CSU will provide comprehensive support services to eligible patients, thereby increasing adherence to screening guidelines and follow-up care. The study focuses on a low-income, predominantly Hispanic and Black population, where lung cancer screening uptake has been particularly low.

Why it matters

Who can join: the full rules

Inclusion Criteria:

Clinic level:

* a NYC RING affiliated clinic,
* Opt into and agree to research protocol;

Patient level:

* Age 50-77 for participants,
* past or current smoker,
* 20+ pack-years tobacco,
* has quit smoking within the last 15 years,
* without chest CT within the past 12 months, and,
* no history of lung cancer or and at least 5 years since the diagnosis of any other malignancy

Exclusion Criteria:

Clinic level:

* only treats pediatric patients,
* Opt out of research protocol;

Patient level:

* Primary care provider instruction to not contact an individual for any reason. Any individual inadvertently contacted who does not meet these criteria will be excluded from the study.

Where it's running

• Montefiore Medical Center's New York City Research and Improvement Networking Group (NYC RING)
  The Bronx, New York, United States Recruiting

Study contacts

• Principal investigator: H. Dean Hosgood, PhD — Albert Einstein College of Medicine
• Study coordinator: H. Dean Hosgood, PhD
• Email: dean.hosgood@einsteinmed.edu
• Phone: 203-215-3275

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• ePRO in advanced lung cancer: emotional distress, brain metastasis, and symptom burden

  This study tests how patients with advanced lung cancer—some with brain metastases—report emotional distress and symptoms over time using electronic questionnaires.

  Recruiting Tongji Hospital · Hubei, Wuhan · NCT07912190

• Urine VOC Test to Detect Lung Cancer in Never Smokers

  A urine test that looks for volatile compounds is tested to see if it can help detect lung cancer in adults who have never smoked.

  Recruiting Thomas Jefferson University · Philadelphia, Pennsylvania · NCT07871656

• SI-B036 safety test in advanced and metastatic solid tumors

  This early-phase study checks whether SI-B036 is safe and tolerable in adults with advanced or metastatic solid cancers who have had prior therapy.

  Recruiting at 4 sites Phase 1 SystImmune Inc. · New Haven, Connecticut and 6 other locations · NCT07857616

• Guaraná Supplement for Cancer-Related Fatigue in People Undergoing Treatment

  This study tests whether taking guaraná capsules helps reduce cancer-related fatigue and improve quality of life in adults with breast, lung, colorectal, or gastric cancer who are actively receiving treatment.

  Recruiting Centro de Tratamiento e Investigación sobre Cáncer, Luis Carlos Sarmiento Angulo · Bogotá, Bogota D.C. · NCT07816263

• ENPP1/cGAS and FAP in Solid Tumors in Vietnamese Patients

  This Vietnam-based study will test ENPP1, cGAS, and FAP expression in archived tumor samples from Vietnamese adults with solid cancers using immunohistochemistry.

  Recruiting at 2 sites Tam Anh Research Institute · Hanoi, Hanoi and 1 other locations · NCT07808164

• Olive oil before lung cancer surgery to see if it lowers chylothorax

  This study tests whether drinking 40 mL of extra-virgin olive oil a few hours before lung cancer surgery can reduce chylothorax after tumor removal.

  Recruiting Fudan University · Shanghai, Xuhui · NCT07807696

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.